01 January 2005
A case report of using hypnosis to treat hot flashes and rheumatic symptoms
Jawaid Younus , Stephen Welch , Howard GranvilleCase Rep Clin Pract Rev 2005; 6:103-106 :: ID: 428827
Abstract
Background: Hot flashes and rheumatic symptoms are experienced by a number of breast cancer survivors treated with adjuvant chemotherapy and Tamoxifen. These patients pose a difficult problem for clinicians responsible for their symptom management. Pharmaceutical interventions are commonly employed, although with limited efficacy and often with side effects. Hypnosis has been found effective for several medical disorders. Various pilot studies and case series have provided some evidence of using hypnosis as a promising non-pharmaceutical treatment option for such resistant symptoms. Case Report: A perimenopausal woman receiving adjuvant Tamoxifen, after chemotherapy for invasive breast cancer developed severe and disabling rheumatologic symptoms and hot flashes. These symptoms were clearly related to the use of Tamoxifen. Supportive pharmaceutical therapy did not improve any of her symptoms. She was offered hypnosis to alleviate these symptoms. The patient experienced significant improvement after two sessions of hypnotherapy. She was subsequently able to tolerate full doses of Tamoxifen and continues to do so. Conclusions: We describe in this case report an example of the utility of clinical hypnosis in the management of hot flashes and rheumatic symptoms. Despite limited clinical experience and evidence, there appears to be an emerging potential role for hypnosis in the management of these diffi- cult symptoms.
Keywords: Hypnosis, Hot Flashes, Rheumatologic symptoms, breast cancer
572
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






